Wataru Nakata

836 total citations
44 papers, 633 citations indexed

About

Wataru Nakata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Wataru Nakata has authored 44 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Wataru Nakata's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and MicroRNA in disease regulation (6 papers). Wataru Nakata is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and MicroRNA in disease regulation (6 papers). Wataru Nakata collaborates with scholars based in Japan, United States and Canada. Wataru Nakata's co-authors include Norio Nonomura, Motohide Uemura, Kazutoshi Fujita, Kazutake Tsujikawa, Kentaro Jingushi, Kaori Kitae, Yuko Ueda, Hiroshi Egawa, Yasutomo Nakai and Akira Nagahara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Wataru Nakata

39 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wataru Nakata Japan 14 408 268 154 109 93 44 633
Charis Kalogirou Germany 14 341 0.8× 324 1.2× 229 1.5× 122 1.1× 100 1.1× 54 654
Jianqun Cai China 14 435 1.1× 290 1.1× 219 1.4× 146 1.3× 154 1.7× 25 768
Jiagen Li China 15 447 1.1× 370 1.4× 206 1.3× 199 1.8× 93 1.0× 42 756
Jeanie Wu Singapore 13 552 1.4× 258 1.0× 149 1.0× 218 2.0× 108 1.2× 14 904
Silvia Bombelli Italy 12 366 0.9× 187 0.7× 287 1.9× 105 1.0× 61 0.7× 22 603
Deyuan Fu China 14 359 0.9× 326 1.2× 101 0.7× 168 1.5× 44 0.5× 35 614
Niklas Klümper Germany 16 443 1.1× 230 0.9× 235 1.5× 280 2.6× 99 1.1× 74 793
Zuo‐Lin Xiang China 13 285 0.7× 241 0.9× 106 0.7× 227 2.1× 77 0.8× 37 633
B Torsello Italy 11 350 0.9× 177 0.7× 281 1.8× 69 0.6× 119 1.3× 19 612

Countries citing papers authored by Wataru Nakata

Since Specialization
Citations

This map shows the geographic impact of Wataru Nakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Nakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Nakata more than expected).

Fields of papers citing papers by Wataru Nakata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Nakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Nakata. The network helps show where Wataru Nakata may publish in the future.

Co-authorship network of co-authors of Wataru Nakata

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Nakata. A scholar is included among the top collaborators of Wataru Nakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Nakata. Wataru Nakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsunoo, Emiru, Yuki Saito, Wataru Nakata, & Hiroshi Saruwatari. (2025). Causal Speech Enhancement with Predicting Semantics based on Quantized Self-supervised Learning Features. 1–5.
2.
3.
Nakata, Wataru, et al.. (2021). A case of long-term complete remission of locally advanced T4 bladder cancer treated with pembrolizumab. Urology Case Reports. 41. 101959–101959. 1 indexed citations
4.
Nakata, Wataru, Tomoki Koriyama, Shinnosuke Takamichi, et al.. (2021). Audiobook Speech Synthesis Conditioned by Cross-Sentence Context-Aware Word Embeddings. 211–215. 9 indexed citations
5.
Kato, Taigo, Akira Nagahara, Norihiko Kawamura, et al.. (2021). Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma. Anticancer Research. 41(11). 5811–5816. 5 indexed citations
6.
Kato, Taigo, Akira Nagahara, Norihiko Kawamura, et al.. (2021). The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study. International Journal of Clinical Oncology. 26(5). 954–961. 7 indexed citations
7.
Kawashima, Atsunari, Yoshiyuki Yamamoto, Wataru Nakata, et al.. (2021). FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab. Scientific Reports. 11(1). 21199–21199. 13 indexed citations
8.
Yamamichi, Gaku, et al.. (2020). High performance of 5‐aminolevulinic acid‐induced fluorescent selective upper tract urinary cytology. International Journal of Urology. 27(3). 213–218. 8 indexed citations
9.
Nakata, Wataru, et al.. (2019). Impact of alternative antiandrogen therapy for Japanese prostate cancer patients in the era of new hormonal therapy. International Journal of Urology. 27(1). 87–89. 1 indexed citations
10.
Yamamichi, Gaku, et al.. (2019). Renal cell carcinoma in a horseshoe kidney treated with robot-assisted partial nephrectomy. Urology Case Reports. 25. 100902–100902. 13 indexed citations
11.
Yamamichi, Gaku, et al.. (2019). High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma. International Journal of Clinical Oncology. 24(9). 1075–1080. 15 indexed citations
12.
Nakata, Wataru, et al.. (2018). Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy. International Journal of Urology. 26(3). 429–431. 3 indexed citations
13.
Yamamoto, Akinaru, Wataru Nakata, Gaku Yamamichi, et al.. (2018). A Rare Case of Vascular Leiomyosarcoma Originating from a Branch Vessel of the External Iliac Vein. Case Reports in Medicine. 2018. 1–4. 4 indexed citations
14.
Yamamichi, Gaku, et al.. (2018). Liposarcoma of the spermatic cord associated with scrotum lipoma: A case report and review of the literature. Urology Case Reports. 17. 114–116. 4 indexed citations
15.
Jingushi, Kentaro, Yuko Ueda, Kaori Kitae, et al.. (2017). High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin. International Journal of Oncology. 51(1). 289–297. 30 indexed citations
16.
Nakata, Wataru, Motohide Uemura, Kazutoshi Fujita, et al.. (2015). Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma. Oncotarget. 6(25). 21645–21654. 34 indexed citations
17.
Jingushi, Kentaro, Yuko Ueda, Kaori Kitae, et al.. (2014). miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC. Molecular Cancer Research. 13(3). 565–574. 67 indexed citations
18.
Fujita, Kazutoshi, Motohide Uemura, Yoshiyuki Yamamoto, et al.. (2014). Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. International Journal of Clinical Oncology. 20(1). 156–163. 22 indexed citations
19.
Nakai, Yasutomo, Wataru Nakata, Takahiro Yoshida, et al.. (2013). EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. PLoS ONE. 8(9). e74313–e74313. 39 indexed citations
20.
Arai, Yasuyuki, Kyosuke Matsuzaki, Yoshiyuki Yamamoto, et al.. (2012). [Cardiac tamponade due to pericardial metastasis from renal cell carcinoma : a case report].. PubMed. 58(9). 491–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charis Kalogirou Breakdown of academic impact, for papers by Jianqun Cai Breakdown of academic impact, for papers by Jiagen Li Breakdown of academic impact, for papers by Jeanie Wu Breakdown of academic impact, for papers by Silvia Bombelli Breakdown of academic impact, for papers by Deyuan Fu Breakdown of academic impact, for papers by Niklas Klümper Breakdown of academic impact, for papers by Zuo‐Lin Xiang Breakdown of academic impact, for papers by B Torsello
Rankless by CCL
2026